What does CUSIP 743187106 represent in this 13F holders report?

CUSIP 743187106 is the security identifier for PGNX - PROGENICS PHARMACEUTICALS IN - COM used to aggregate holder disclosures.

How many institutions held PGNX - PROGENICS PHARMACEUTICALS IN - COM in Q3 2014?

76 institutional investors reported PGNX - PROGENICS PHARMACEUTICALS IN - COM for Q3 2014. Use the holders table for investor-level position and value details.

PROGENICS PHARMACEUTICALS IN - COM (PGNX)

CUSIP: 743187106

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class: Equity / COM
Total 13F shares: 56,456,747
Share change: +5,680,391
Total reported value: $293,007,558
Put/Call ratio: 91%
Price per share: $5.19
Number of holders: 76
Value change: +$30,164,921
Number of buys: 36
Number of sells: 36

Quarterly Holders Quick Answers

What is CUSIP 743187106?
CUSIP 743187106 identifies PGNX - PROGENICS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2014
Previous quarter: Q2 2014

Recent filing periods for CUSIP 743187106:

Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018

Institutional Holders of PROGENICS PHARMACEUTICALS IN - COM (PGNX) as of Q3 2014

As of 30 Sep 2014, PROGENICS PHARMACEUTICALS IN - COM (PGNX) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,456,747 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, FMR LLC, BAKER BROS. ADVISORS LP, BlackRock Fund Advisors, TUDOR INVESTMENT CORP ET AL, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, HIGHLAND CAPITAL MANAGEMENT LP, and WELLINGTON MANAGEMENT CO LLP. This page lists 76 institutional shareholders reporting positions in this security for the Q3 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.